McKesson Corp. (MCK)

153.96
2.30 1.50
NYSE : Distribution Services
Prev Close 151.71
Open 153.00
Day Low/High 150.17 / 154.20
52 Wk Low/High 134.25 / 178.86
Volume 1.82M
Avg Volume 1.72M
Exchange NYSE
Shares Outstanding 206.34M
Market Cap 30.72B
EPS 23.40
P/E Ratio 6.79
Div & Yield 1.36 (0.88%)

Latest News

Jim Cramer: It's All About Expectations

Jim Cramer: It's All About Expectations

Earnings season is already seeing some wacky effects.

Congress Sets Opioid Hearing Next Month for Drug Distributors

Congress Sets Opioid Hearing Next Month for Drug Distributors

A House committee trying to understand how the opioid crisis came to be and what to do next has set a May 8 hearing for drug distributors to explain their role.

American Medical Association Rejects Idea of Time Limits on Opioid Scripts

American Medical Association Rejects Idea of Time Limits on Opioid Scripts

While more than half the states in the U.S. have passed time limits on opioid prescription as a way to battle the epidemic, the AMA says that should be left up to the doctor and patient.

McKesson Lawsuit Puts Drug Distributors Back Into Harsh Public Spotlight

McKesson Lawsuit Puts Drug Distributors Back Into Harsh Public Spotlight

McKesson and other drug distributors are having a difficult time steering clear of controversy, with the latest blow a lawsuit alleging McKesson has violated the False Claims Act.

Searching For Buy Signals; Activists Pile Into United Technologies - ICYMI

Searching For Buy Signals; Activists Pile Into United Technologies - ICYMI

Amid the decline there were some winners including Red Hat and McCormick. Twitter gets a new short-seller and more activist action at United Technologies, dot a busy Tuesday. Here's what you may have missed.

Trump Opioid Policy Rollout Includes Call for Death Penalty for Dealers

Trump Opioid Policy Rollout Includes Call for Death Penalty for Dealers

President Trump made a long-awaited announcement of his administration's opioid plan in a New Hampshire speech that was part policy roll out and part political rally.

Study: Over-the-Counter Meds More Effective For Chronic Back Pain Than Opioids

Study: Over-the-Counter Meds More Effective For Chronic Back Pain Than Opioids

A study published by the Journal of the American Medical Association shows OTC drugs were more effective in cutting pain for chronic back pain and osteoarthritis hip and knee patients than opioids.

Attorney General Sessions Announces New Federal Opioids Taskforce

Attorney General Sessions Announces New Federal Opioids Taskforce

After months of inaction by the federal government on the crisis regarding opioid abuse, Attorney General Jeff Sessions announced the creation of a task force charged with looking at how drug makers and distributors operate.

McKesson Corporation Announces Pricing Of Tender Offer

McKesson Corporation Announces Pricing Of Tender Offer

McKesson Corporation (NYSE: MCK) (the "Company") today announced the determination of the Full Tender Offer Consideration, as shown in the table below, for its previously announced cash tender offer to purchase up to...

See How McKesson Ranks Among Analysts' Top Picks With Strong Buyback Activity

See How McKesson Ranks Among Analysts' Top Picks With Strong Buyback Activity

A study of analyst recommendations at the major brokerages shows that McKesson Corp is the #33 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.

McKesson Corporation Announces Early Tender Results

McKesson Corporation Announces Early Tender Results

McKesson Corporation (NYSE: MCK) (the "Company") today announced the early tender results as of the Early Tender Time (as defined below) in connection with its previously announced cash tender offer to purchase up to...

House Committee: 2 Pharmacy Managers Sent 12.3 Million Opioid Doses to 1 Store

House Committee: 2 Pharmacy Managers Sent 12.3 Million Opioid Doses to 1 Store

McKesson and Cardinal Health are alleged to have sent more than 12 million opioid doses to a single pharmacy in West Virginia over an eight-year period, according to a House committee probe.

Who Says There Are No Second Chances?

Who Says There Are No Second Chances?

A follow-up on my stock pick of the year, McKesson.

Medical Supply Stocks Get Hit in Latest Example of the 'Amazon Effect'

Medical Supply Stocks Get Hit in Latest Example of the 'Amazon Effect'

In the last two weeks alone, three sectors have gotten hammered on announcements or reports about Amazon's plans.

Purdue Pharma to Downplay Opioids, Dump 50% of Sales Staff

Purdue Pharma to Downplay Opioids, Dump 50% of Sales Staff

As lawsuits tied to the opioid crisis keep piling up, Purdue Pharma is discontinuing direct sales calls to doctors. Will other opioid makers follow suit?

Drug Supply Chain Stocks Dip After White House Recommendations on Drug Pricing

Drug Supply Chain Stocks Dip After White House Recommendations on Drug Pricing

The White House Council of Economic Advisers on Friday, Feb. 9, released a report on how the government can help bring down drug prices.

The Really Big Money Rushes to Super Bowl

The Really Big Money Rushes to Super Bowl

This will be the ninth consecutive year when the big game tops that 100 million-viewers mark.

McKesson Reports Fiscal 2018 Third-Quarter Results

McKesson Reports Fiscal 2018 Third-Quarter Results

McKesson Corporation (NYSE:MCK) today reported that revenues for the third quarter ended December 31, 2017, were $53.

Managed Care Stocks Thrashed on Amazon News but Could Be Buying Opportunity

Managed Care Stocks Thrashed on Amazon News but Could Be Buying Opportunity

The stocks of healthcare giants such as United, Cigna and Anthem tumbled Tuesday following news that Amazon, Berkshire Hathaway and JPMorgan have banded together on a healthcare initiative for their workers.

NYC Joins Cities, Counties and States In Bringing Opioid Lawsuit

NYC Joins Cities, Counties and States In Bringing Opioid Lawsuit

New York City sues Purdue Pharma, Teva Pharmaceutical, Allergan, Johnson and Johnson, Endo International, McKesson, AmerisourceBergen and Cardinal Health over how opioids have devastated the city and its services.

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

It's hard to understand the magnitude of the change.

Opioids Get Their Day In Washington, but Effort To Dump Medicaid Gets Spotlight

Opioids Get Their Day In Washington, but Effort To Dump Medicaid Gets Spotlight

As opioid crisis becomes more deadly, public hearings put the pain killers front and center. But in bitterly divided Washington one meeting is more about chopping Medicaid.

Jim Cramer: I Blame the Pajama Traders for This Selloff

Jim Cramer: I Blame the Pajama Traders for This Selloff

They make more irrational, stupid moves based on nothing than I ever thought possible.

Cramer: 5 Rules for Our Beast of a Bull Market

Cramer: 5 Rules for Our Beast of a Bull Market

It might look easy now, but it looked easy in 1999, too.

McKesson Becomes #134 Most Shorted S&P 500 Component, Replacing Textron

McKesson Becomes #134 Most Shorted S&P 500 Component, Replacing Textron

The most recent short interest data has been released for the 12/29/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

McKesson CEO: It's 'Nonsense' We Haven't Done Enough to Combat Opioid Crisis

McKesson CEO: It's 'Nonsense' We Haven't Done Enough to Combat Opioid Crisis

In the past few weeks, McKesson has been unhappily tied to stories about opioids, including coverage on TheStreet. At the JPMorgan Healthcare Conference, the company took its case to investors.

America's Opioid Crisis Looks a Lot Like Big Tobacco Spats of Yesteryear

America's Opioid Crisis Looks a Lot Like Big Tobacco Spats of Yesteryear

The crisis could seemingly turn a number of companies on their heads much in the way that big tobacco suits of the late 1990s forever changed the tobacco industry.

A Controversial Pick of the Year for 2018

A Controversial Pick of the Year for 2018

Nothing breeds future investment success like buying in the face of negative headlines.

TheStreet Quant Rating: C+ (Hold)